H.R. 601 · 116th Congress
Medical Cannabis Research Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
12 cosponsors · 8 D, 4 R
4 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill establishes a new, separate registration process for manufacturers of cannabis for research.
What it does: CRS summary · Introduced in House · Jan 16, 2019
Medical Cannabis Research Act of 2019
This bill establishes a new, separate registration process for manufacturers of cannabis for research.
As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.
The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medical Cannabis Research Act of 2019
Latest action (Mar 4, 2019): Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Policy area: Health · Origin: House · Introduced: Jan 16, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.